Anzeige
Mehr »
Samstag, 05.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
911 Leser
Artikel bewerten:
(2)

Visiongain Report Looks at Opportunities within the $75bn Vaccines Sales Market

Global Vaccines Sales Market Forecast 2019-2029

Paediatric Vaccines, Adult Vaccines, Elderly Vaccines, Travel Vaccines, Therapeutic Vaccines, Prevnar, Gardasil, Fluzone, Pentacel, ProQuad, Infanrix/Pediarix, Zostavax, RotaTeq, Menactra

LONDON, Sept. 4, 2019 /PRNewswire/ -- The global vaccines market is estimated at $41bn in 2018 and is expected to grow at a CAGR of 10.9% during the forecast period. The Paediatric Vaccines segment held 56% of the Global Vaccines market in 2018.

Visiongain Logo

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 121 charts- all unavailable elsewhere.

The 201-page report provides clear detailed insight into the global vaccines sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-vaccines-sales-market-forecast-2019-2029/download_sampe_div

Report Scope

• Global Vaccines Sales Market forecasts from 2019-2029

• Global Vaccines Sales Market forecasts from 2019-2029 by Submarket:
• Paediatric Vaccines
• Adult Vaccines
• Elderly Vaccines
• Travel Vaccines
• Therapeutic Vaccines

• Global Vaccines Sales Market forecasts from 2019-2029 by Leading Vaccines:
• Prevnar
• Gardasil
• Fluzone
• Pentacel
• ProQuad
• Infanrix/Pediarix
• Zostavax
• RotaTeq
• Hepatitis Vaccines
• Menactra

• Global Vaccines Sales Market forecasts from 2019-2029 by Regional and National Market:
• US
• EU5: Germany, France, Italy, UK, Spain
Japan
Brazil
Russia
India
China

• Profiles of the selected leading companies:
• AstraZeneca
• Eli Lilly
• Emergent BioSolutions Inc.
• GlaxoSmithKline
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Sanofi
• Serum Indian Institute Pvt. Ltd.
• Takeda

• The Vaccines Market Pipeline Analysis

• A SWOT and STEP analysis of the global vaccines market

• Key Questions Answered by this Report:
• What is the current size of the overall global human vaccines market? How much will this market be worth from 2018 to 2029?
• What are the main drivers and restraints that will shape the overall vaccines market over the next ten years?
• What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2018 to 2029? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world vaccines? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2028?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2029, and which geographical region will lead the market in 2029?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are the leading vaccines? What are their revenues and latest developments?
• What are some of the most prominent human vaccines currently in development?
• What are the main trends that will affect the world vaccines market between 2018 and 2029?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the global vaccines market evolve over the forecasted period, 2018 to 2029?
• How will the market shares for each checkpoint inhibitor anti-cancer treatment submarket develop from 2018 to 2029?
• Which therapies can succeed and what revenues could they generate to 2029?
• What will be the main commercial drivers for the market from 2018 to 2029?
• How will market shares of prominent national markets change from 2018, and which countries will lead the market in 2029, achieving highest revenues and fastest growth?
• How will that industry evolve between 2018 and 2029, especially in R&D?

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-vaccines-sales-market-forecast-2019-2029/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

AstraZeneca
Bavarian Nordic
Bayer
Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL)
Binnopharm
BiondVax
Bristol-Myers Squibb
Chemo-Sero-Therapeutic Research Institute
China National Biotec Group
Denka Seiken
Eli Lilly
Emergent BioSolutions Inc
Fresenius
GlaxoSmithKline (GSK)
GlaxoWellcome
Henogen
Immatics
InterveXion Therapeutics
Johnson & Johnson
LigoCyte
MedImmune
Merck & Co.
Merck Sharp & Dohme Corp
Nanolek
NewLink Genetics
Okairos
PaxVax
Pfizer
Protein Science
Roche
Sanofi Pasteur
Serum Indian Institute Pvt. Ltd.
SmithKline Beecham
Takeda
Themis Bioscience

Organizations Mentioned in the Report
Centers for Disease Control and Protection (CDC)
Centre for Biologics Evaluation and Research (CBER)
Developing Countries Vaccine Manufacturers Network (DCVMN)
European Medicines Agency (EMA)
Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Food and Drug Administration (FDA)
Global Alliance for Vaccines
Global Alliance for Vaccines and Immunization (GAVI)
International Financing Facility for Immunisation
National Health Service (NHS)
Pan American Health Organization (PAHO)
The Butantan Institute
The Indian Department of Biotech
The Ministry of Health, Labour and Welfare and the Health Service Bureau
UNICEF
World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

Global Pre-Filled Syringes Market Forecast 2019-2029

Top 20 Vaccines Manufacturers 2019

Drug Delivery Technologies Market Forecast 2019-2029

Lyophilization in Pharmaceutical Market Forecast 2019-2029

Global Vaccine Contract Manufacturing Market Report 2019-2029

mRNA Vaccines and Therapeutics Market Forecast 2019-2029

Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

© 2019 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.